Isamu Sugimoto
Hokkaido University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Isamu Sugimoto.
Bioorganic & Medicinal Chemistry Letters | 2010
Masaki Asada; Tetsuo Obitsu; Atsushi Kinoshita; Yoshihiko Nakai; Toshihiko Nagase; Isamu Sugimoto; Motoyuki Tanaka; Hiroya Takizawa; Ken Yoshikawa; Kazutoyo Sato; Masami Narita; Shuichi Ohuchida; Hisao Nakai; Masaaki Toda
A series of novel N-acylsulfonamide analogs were synthesized and evaluated for their binding affinity and antagonist activity for the EP3 receptor subtype. Representative compounds were also evaluated for their inhibitory effect on PGE(2)-induced uterine contraction in pregnant rats. Among those tested, a series of N-acylbenzenesulfonamide analogs were found to be more potent than the corresponding carboxylic acid analogs in both the in vitro and in vivo evaluations. The structure activity relationships (SAR) are also discussed.
Bioorganic & Medicinal Chemistry | 2009
Masaki Asada; Tetsuo Obitsu; Toshihiko Nagase; Isamu Sugimoto; Yoshiyulci Yamaura; Kazutoyo Sato; Masami Narita; Shuichi Ohuchida; Hisao Nakai; Masaaki Toda
A series of acrylic acids and their structurally related compounds were evaluated for their binding affinity to four EP receptor subtypes (EP1-4). Starting from the initial hit 3, which was discovered in our in-house library, compounds 4 and 5 were identified as new chemical leads as candidates for further optimization towards a selective EP3 receptor antagonist. The identification process of these compounds and their pharmacokinetic profiles are presented.
Bioorganic & Medicinal Chemistry | 2012
Tetsuji Saito; Tetsuo Obitsu; Hiroshi Kohno; Isamu Sugimoto; Takeshi Matsushita; Taihei Nishiyama; Tomoko Hirota; Hiroyuki Takeda; Naoya Matsumura; Sonoko Ueno; Akihiro Kishi; Yoshifumi Kagamiishi; Hisao Nakai; Yoshikazu Takaoka
To identify structurally novel corticotropin-releasing factor 1 (CRF(1)) receptor antagonists, a series of bicyclic core analogs pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f]triazin-4(3H)-ones, which were designed based on a monocyclic core antagonist, was synthesized and evaluated. Among the compounds tested, 2-difluoromethoxy-4-methylpyridin-5-yl analog 27 was found to show efficacy in a dose-dependent manner in an elevated plus maze test in rats. The discovery process and structure-activity relationship is presented.
Tetrahedron | 2000
Yoshihito Ueno; Keisuke Tomino; Isamu Sugimoto; Akira Matsuda
Abstract Synthesis and properties of the 4′α- C -(2-aminoethyl)thymidine ( 1 )-containing oligodeoxynucleotides (ODNs), which have lipophilic groups such as palmitic acid, oleic acid, and cholesterol at the terminal of the aminoethyl linker of the compound 1 , are described. The ODNs were synthesized in a DNA synthesizer by using controlled pore glasses (CPGs) having the 4′α- C -[ N -(palmitoyl), N -(oleoyl), and N -(cholesteryloxycarbonyl)aminoethyl]thymidine analogs ( 9a , b , and c ). The stability of the duplexes formed by these ODNs and a complementary DNA 15 or RNA 16 was studied by thermal denaturation. It was found that the bulky functional group such as cholesterol thermally destabilizes the DNA/DNA duplexes, but that such thermal destabilization can be offset by the effects of the aminoethyl linker of 1 . Furthermore, these lipophilic groups do not largely influence the thermal stability of the DNA/RNA duplexes.
ACS Medicinal Chemistry Letters | 2017
Isamu Sugimoto; Tohru Kambe; Tomotaka Okino; Tetsuo Obitsu; Nobukazu Ohta; Taihei Nishiyama; Akihiro Kinoshita; Taku Fujimoto; Hiromu Egashira; Shinsaku Yamane; Satoshi Shuto; Kousuke Tani; Toru Maruyama
A novel series of prostaglandin analogues with a seven-membered ring scaffold was designed, synthesized, and evaluated for the functional activation of prostaglandin receptors to identify potent and subtype-selective FP and EP3 dual agonists. Starting from the prostacyclin derivative 5b, a nonselective agonist for prostaglandin receptors, replacement of the core structure with an octahydro-2H-cyclopenta[b]oxepine scaffold led to the discovery of the potent and selective FP and EP3 dual agonist 11b as a lead compound for the development of an antiglaucoma agent.
Bioorganic & Medicinal Chemistry Letters | 1999
Isamu Sugimoto; Satoshi Shuto; Shuichi Mori; Shiro Shigeta; Akira Matsuda
Bioorganic & Medicinal Chemistry | 2004
Kazuhiko Torisu; Kaoru Kobayashi; Maki Iwahashi; Yoshihiko Nakai; Takahiro Onoda; Toshihiko Nagase; Isamu Sugimoto; Yutaka Okada; Ryoji Matsumoto; Fumio Nanbu; Shuichi Ohuchida; Hisao Nakai; Masaaki Toda
Journal of Organic Chemistry | 1998
Yoshihito Ueno; Yuki Nagasawa; Isamu Sugimoto; Naoshi Kojima; Makiko Kanazaki; Satoshi Shuto; Akira Matsuda
Journal of Organic Chemistry | 1999
Isamu Sugimoto; and Satoshi Shuto; Akira Matsuda
Journal of the American Chemical Society | 2000
Satoshi Shuto; Isamu Sugimoto; Hiroshi Abe; Akira Matsuda